ES357954A1 - Procedimiento para la estabilizacion de acido alfa-lipoico en soluciones farmaceuticas. - Google Patents
Procedimiento para la estabilizacion de acido alfa-lipoico en soluciones farmaceuticas.Info
- Publication number
- ES357954A1 ES357954A1 ES357954A ES357954A ES357954A1 ES 357954 A1 ES357954 A1 ES 357954A1 ES 357954 A ES357954 A ES 357954A ES 357954 A ES357954 A ES 357954A ES 357954 A1 ES357954 A1 ES 357954A1
- Authority
- ES
- Spain
- Prior art keywords
- alpha
- lipoic acid
- translation
- machine
- legally binding
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- AGBQKNBQESQNJD-UHFFFAOYSA-N lipoic acid Chemical compound OC(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-N 0.000 title abstract 6
- 235000019136 lipoic acid Nutrition 0.000 title abstract 3
- 229960002663 thioctic acid Drugs 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 2
- 239000003186 pharmaceutical solution Substances 0.000 title abstract 2
- 230000006641 stabilisation Effects 0.000 title 1
- 238000011105 stabilization Methods 0.000 title 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 238000001802 infusion Methods 0.000 abstract 1
- 230000001681 protective effect Effects 0.000 abstract 1
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 abstract 1
- 239000000243 solution Substances 0.000 abstract 1
- 230000000087 stabilizing effect Effects 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 229940011671 vitamin b6 Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE1617740 | 1967-09-25 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES357954A1 true ES357954A1 (es) | 1970-04-01 |
Family
ID=5682288
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES357954A Expired ES357954A1 (es) | 1967-09-25 | 1968-09-09 | Procedimiento para la estabilizacion de acido alfa-lipoico en soluciones farmaceuticas. |
Country Status (4)
| Country | Link |
|---|---|
| AT (1) | AT275737B (es) |
| DE (1) | DE1617740B1 (es) |
| ES (1) | ES357954A1 (es) |
| FR (1) | FR1605097A (es) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE70974T1 (de) * | 1987-12-04 | 1992-01-15 | Asta Pharma Ag | Injizierbare loesung des thioctsaeuresalzes mit trometamol und/oder basischen aminosaeuren. |
| DK0427246T3 (da) * | 1989-11-09 | 1995-11-27 | Asta Medica Ag | Lægemiddel, der som aktivt middel indeholder svovlholdige carboxylsyrer, samt anvendelse deraf til bekæmpelse af retrovira |
| DE102004050353A1 (de) * | 2004-10-15 | 2006-04-20 | Basf Ag | Verwendung stabiler Ammoniumsalze der Liponsäure zur Behandlung diabetischer und weiterer Störungen |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1205972B (de) * | 1963-08-20 | 1965-12-02 | Merck Ag E | Verfahren zur Herstellung eines Liponsaeure-derivates |
-
1967
- 1967-09-25 DE DE1967P0043060 patent/DE1617740B1/de not_active Withdrawn
- 1967-12-19 AT AT1145467A patent/AT275737B/de active
-
1968
- 1968-09-09 ES ES357954A patent/ES357954A1/es not_active Expired
- 1968-09-18 FR FR1605097D patent/FR1605097A/fr not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| FR1605097A (en) | 1973-01-12 |
| DE1617740B1 (de) | 1971-11-04 |
| AT275737B (de) | 1969-11-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES329052A1 (es) | Metodo de produccion de preparaciones farmaceuticas. | |
| ES357954A1 (es) | Procedimiento para la estabilizacion de acido alfa-lipoico en soluciones farmaceuticas. | |
| CH553781A (de) | Verfahren zur herstellung von nikotinsaeure-derivaten von vitamin-b6-verbindungen. | |
| ES286699A1 (es) | Un método de influir en el crecimiento de las plantas | |
| ES312859A2 (es) | Un procedimiento para preparar soluciones acuosas y estables de formaldehido. | |
| ES325416A1 (es) | Procedimiento para la obtencion de tabletas estables que contienen vitamina c. | |
| ES334745A1 (es) | Metodo para el tratamiento de una solucion galvanoplastica acida de estaño. | |
| ES384063A1 (es) | Procedimiento para la preparacion de soluciones acuosas es-tables de cardenolidas sensibles a la oxidacion. | |
| ES332902A1 (es) | Procedimiento para la estabilizacion de poliamidas. | |
| ES268449A1 (es) | Proceso para la preparaciën de un miembro del grupo consistente en una sal de pamoato acido de furaltadona y un hidrato de la misma | |
| ES247110A1 (es) | Un metodo para la preparaciën de salicilato de colina cristalino, una soluciën acuosa de este o preparaciones terapeuticas del mismo | |
| ES304340A1 (es) | Procedimiento para la obturaciën de soluciones de albumina humana con bajo contenido en sodio | |
| ES262213A3 (es) | Un procedimiento para preparar un producto insoluble en agua de vitamina b12 | |
| ES324596A1 (es) | Procedimiento para la preparacion de sales de piridoxina. | |
| ES302294A1 (es) | Procedimiento para preparar compuestos complejos con yoduro de bismuto de la 2-dehidroemetina. | |
| ES380903A1 (es) | Un metodo de obtencion de dos sales, biologicamente activas, del acido 2-propilvalerico. | |
| ES238763A1 (es) | Procedimiento para la obtenciën de un producto multivitaminico acuoso que contenga vitamina b12 en forma estable | |
| ES366888A1 (es) | Procedimiento para la obtencion de 1-(2-nitrilo-fenoxi) - 2 - hidroxi - 3 - isopropilaminopropano y sus sales. | |
| ES295377A1 (es) | Procedimiento para la obtencion de ésteres de acido isovalerianico | |
| FR1296497A (fr) | Procédé perfectionné de préparation de la vitamine b | |
| ES279694A1 (es) | Procedimiento para la preparaciën de decanoatos de derivados de ciclopentano-polhidrofenantreno | |
| ES288987A1 (es) | Procedimiento de obtencion de productos farmaceuticos para la terapia salicilica | |
| ES295638A1 (es) | Procedimiento de estabilización de soluciones acuosas de peróxido de hidrógeno | |
| FR95564E (fr) | Nouveau procédé de préparation de la phosphocréatinine. | |
| ES315330A1 (es) | Procedimiento para la monohidratacion del complejo equimolecular formado por acido ascorbico y piridoxina. |